Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction
- Status
- COMPLETED
- Phase
- PHASE4
Surefire Institutional DEB-TACE
- Status
- UNKNOWN
- Phase
- NA
Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®
- Status
- TERMINATED
- Phase
- N/A
Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE1
IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
- Status
- RECRUITING
- Phase
- PHASE1
Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence
- Status
- COMPLETED
- Phase
- N/A
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
- Status
- UNKNOWN
- Phase
- PHASE3
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
- Status
- UNKNOWN
- Phase
- PHASE3
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combined HCC-MFCCC
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
- Status
- COMPLETED
- Phase
- NA
Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE1
Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE1
Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)
- Status
- WITHDRAWN
- Phase
- NA
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1